SFU drug researchers receive a boost from the province

SFU drug researchers will be receiving a boost thanks to $13-million in provincial funding for the Centre for Drug Research and Development (CDRD).  

The CDRD is a national drug development institution founded in 2007 that translates commercially promising health research conducted at universities into innovative new therapies that improve and save lives. The funding will pave the way for drug breakthroughs at SFU and other partner institutions to reach the public.  

Chemistry professors Robert Young and David Vocadlo are among the SFU researchers whose work benefits from the access to the CDRD facilities. 

“SFU is a proud founding partner of the CDRD,” says Joy Johnson, SFU’s Vice-President of Research and International, and CDRD board member. “SFU’s commitment to CDRD is a key part of our SFU Innovates strategy. This funding will help facilitate the impact-oriented research and innovation led by SFU researchers such as Professors Young and Vocadlo, and allow the research to benefit all Canadians.” 

CDRD was founded on a shared vision between government, industry and academia. The funding announcement by Ministers Terry Lake and Amrik Virk further carries out this important vision. 


Transforming drug research and development in B.C.

(Minister Amrik Virk discussing #BCTECH strategy and strength in life sciences at the CDRD announcement on November 23, 2016)